If you work in pharmaceuticals, healthcare, or clinical research, you’ll know that two numbers define more of your supply chain than almost anything else: 2 and 8. The range of 2–8°C is the internationally recognised standard for storing and transporting a vast category of temperature-sensitive medicines, vaccines, and biological materials, and even a brief excursion outside it can compromise an entire shipment.
At FET Logistics, we are here to explain why this specific range matters so much, what risks arise when it’s not maintained, and what GDP-compliant cold chain logistics providers do to protect it end to end.
What products require 2–8°C transport?
The chilled range covers a wider range of products than most people realise. Common examples include:
- Vaccines and immunological products, including influenza, meningitis, and HPV vaccines
- Monoclonal antibodies and biologics, which are sensitive to both heat and freezing
- Insulin and other hormone-based medicines
- Blood products and plasma, including fresh frozen plasma and packed red cells
- Clinical trial investigational medicinal products (IMPs), where even minor temperature deviations can invalidate trial data
- Advanced Therapy Medicinal Products (ATMPs), such as gene therapies and cell-based treatments
What these products share is that their efficacy depends on maintaining a stable cold but not frozen environment. Too warm, and the active compound degrades. Too cold, and some products (particularly certain biologics and insulin) can denature irreversibly.
Why excursions happen, and why they matter
A temperature excursion is any deviation outside the validated range during storage or transit.
Common causes in the 2–8°C range include door openings during handoffs, poorly pre-conditioned vehicles, ambient temperature extremes during summer or winter transit, and delays at airports or customs where goods sit without active temperature control.
The consequences are significant. Depending on the product, an excursion may require a stability assessment by the manufacturer, a quarantine decision, or full batch rejection. For clinical trials, a compromised shipment can mean delayed patient dosing, protocol deviations, and in some cases, the invalidation of a trial arm.
What GDP-compliant transport looks like in practice
Good Distribution Practice (GDP), as defined by the MHRA and EU guidelines, sets out specific requirements for transporting medicinal products. For 2–8°C shipments, this translates to several operational realities:
Vehicle qualification and thermal mapping
Vehicles used for chilled transport must be thermally mapped, a process that involves placing sensors throughout the load space to identify any warm or cold spots. Mapping is conducted under both summer and winter conditions. Only validated routes and load configurations should be used for commercial shipments.
Pre-conditioning
The refrigerated compartment must be pre-conditioned to the target range before loading. Loading into a warm vehicle, even briefly, creates an immediate excursion risk for products stored at the surface of the pallet.
Independent data loggers
Regulatory guidance requires that temperature data be recorded by an independent logger, separate from the vehicle’s own refrigeration system, so there is an auditable record that can be provided to the consignee and, where required, to regulators.
24/7 monitoring and intervention
Modern GDP-compliant providers operate a 24/7 control centre with live telematics. If a logger reading moves towards the boundary of the validated range, the control centre can intervene, contacting the driver, arranging a contingency vehicle, or alerting the client, before an excursion is confirmed.
The hidden risk: the last mile
Most temperature excursions in 2–8°C cold chains do not occur in the main transit vehicle. They occur during handoffs, at the airport airside, during cross-docking, or at the point of delivery when a product is transferred from an active vehicle to an uncontrolled environment. Experienced cold chain providers use validated passive packaging, pre-conditioned cool boxes, or ‘keep-cool’ pouches for these last-mile scenarios, and specify maximum time-out-of-refrigeration limits in their standard operating procedures.
Choosing a 2–8°C transport partner
When evaluating a cold chain logistics provider for chilled shipments, look beyond the vehicle specification. Key questions include:
- Are vehicles thermally mapped under both summer and winter conditions?
- Is temperature monitoring independent from the refrigeration system?
- Does the provider have a 24/7 control centre staffed by trained personnel?
- Are drivers GDP-trained and able to respond to temperature alerts?
- Can the provider provide full temperature records at point of delivery?
- What is the contingency plan if a vehicle breaks down mid-journey?
These questions distinguish providers who simply have refrigerated vehicles from those who operate a managed, auditable cold chain.
Need GDP-compliant 2–8°C transport?
Contact FET Logistics today or call our 24/7 control centre.
View more blog posts



